Vaccine, Delivery

Grand View Research, Inc. United States of America United Kingdom

25.07.2017 - 12:32:48

Vaccine Delivery Devices Market Size Worth $6.21 Billion by 2025: Grand View Research, Inc.


Adoption of needle-free approach for administering these products is gaining momentum due to growing awareness and demand to avoid pain & injuries associated with the use of a needle stick. Data by the Centers for Disease Control and Prevention states that an estimated 385,000 sharp injuries including needle stick injuries occur every year in hospitals in the U.S. Advancing technologies in administering vaccines and their increasing adoption is propelling market growth. Rising interest of various key players, national institutions, and organizations in novel delivery technologies is expected to further contribute to market growth.

Various governments and international organizations are increasingly investing in the development of vaccination programs. For instance, the UK government also announced funding up to £1 million from its Global Challenges Research Fund through Medical Research Council to investigate the Zika virus and its transmission. Organizations such as GAVI Alliance, Bill & Melinda Gates Foundation, Path, and WHO are actively involved in the field of vaccines. Many governments are also undertaking several immunization programs on priority.

Browse full research report with TOC on "Vaccine Delivery Devices Market Analysis By Devices (Syringes, Jet Injectors, Other Devices), By Route of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination, Others), And Segment Forecasts, 2014 - 2025" at:

Further key findings from the report suggest: 

The syringes segment held majority of the revenue share in 2016 due to increasing vaccination programs, spreading immunization coverage, and technological advancementsJet injectors is expected to register highest growth during the forecast period owing to rising concerns regarding needle stick injuries and growing preference for needle-free technologiesIntramuscular vaccination dominated the route of administration segment in 2016 as majority of vaccines are given through this route owing to its advantagesNorth America dominated the global market owing to increasing awareness levels, high adoption of technology, and rising prevalence of infectious diseasesSome of the key players include Becton Dickinson & Company, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.); Gerresheimer AG; PharmaJet; Corium International, Inc.; and SCHOTT AG

Browse related reports by Grand View Research: 

Fluid Management Systems Market -
Kidney Fibrosis Treatment Market -
Gastrointestinal Endoscopic Devices Market-
Acute Coronary Syndrome Market-

Grand View Research has segmented the vaccine delivery devices market on the basis of devices, route of administration, and region: 

Devices Outlook (Revenue, USD Million, 2014 - 2025) SyringesJet InjectorsOther DevicesRoute of Administration Outlook (Revenue, USD Million, 2014 - 2025) Intradermal VaccinationIntramuscular vaccinationSubcutaneous VaccinationOther VaccinationsRegional Outlook (Revenue, USD Million, 2014 - 2025) North AmericaU.S.CanadaEuropeGermanyUKAsia PacificChinaJapanLatin AmericaBrazilMexicoMiddle East & AfricaSouth Africa

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519



Amazon wird sich schwarzärgern, aber …

… wir schenken Ihnen den Report „Börsenpsychologie - Markttechnik für Trader“ heute trotzdem kostenfrei. Normalerweise kostet der Report im Onlinehandel 39,99 Euro.

Sie können sich den genialen Report heute jedoch absolut kostenfrei sichern. Wir senden Ihnen den Report vollkommen KOSTENFREI zu.

Jetzt HIER klicken und dank richtigen Timing reich an der Börse werden!